Netherlands
Summary
This business specializes in the development and provision of pharmaceutical products, particularly focusing on biologic therapies for various medical conditions. It offers a range of medications, including Natalizumab, Adalimumab, Infliximab, and Etanercept, which are used to treat autoimmune diseases and other serious health conditions. The company emphasizes risk minimization strategies and provides additional materials to help healthcare professionals manage the risks associated with these medications.
Based on content on biogen-armm.nl
No similar companies found
We offer API access to our data.
6 of 8 checks passed
Label
Value
Active Dates
3.1 years — Since Nov 2021
Web Hosting
Platform
E-Mail Provider
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Pharmaceuticals and Biotechnology
2. Pharmaceutical Preparation Manufacturing
No vendors identified.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|